nach oben

Current Anesthesiology Reports

Erschienen in:

10.11.2023 | Anesthesia, Pain Management and Long-term Outcomes (VNR Gottumukkala and ER Mariano, Section Editors)

Perioperative Blood Management Protocols Improve Outcomes: What Does the Future Hold?

verfasst von: Sachin Mehta, Sharon L. McCartney, Nicole R. Guinn, Elliott Bennett-Guerrero

Erschienen in: Current Anesthesiology Reports | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This manuscript aims to review the current state of perioperative blood management as well as prognosticate future directions for the field.

Recent Findings

Perioperative blood management is a broad topic with a core tenet of conserving a patient’s own blood throughout the perioperative period. This manuscript provides an overview of the recent literature in this area and examines several treatment strategies to mitigate the risk of allogeneic transfusions. Some examples of topics covered include hemoglobin optimization, intraoperative techniques to minimize blood loss, and postoperative anemia tolerance and mitigation.

Summary

In the modern perioperative arena, perioperative blood management is a vital strategy to enhance patient care with the goal of reducing resource utilization and achieving better outcomes. A focus on patient-specific risk factors as well as surgical context is important to optimize benefits from perioperative blood management.

Shander A, Hardy JF, Ozawa S, Farmer SL, Hofmann A, Frank SM, Kor DJ, Faraoni D, Freedman J, Collaborators. A global definition of patient blood management. Anesth Analg. 2022;135(3):476–88 A multinational group of patient blood management experts proposed a PBM definition and created an overview of its scope and possible best practices.PubMedCrossRef

WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. In: Vitamin and Mineral Nutrition Information System. Geneva, Switzerland: World Health Organization; 2011. Available at:http://www.who.int/vmnis/indicators/haemoglobin.pdf. Accessed 31 May 2023.

Spahn DR, Schoenrath F, Spahn GH, et al. Effect of ultra- short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomized trial. Lancet. 2019;393:2201–12.PubMedCrossRef

Kong R, Hutchinson N, Hill A, Ingoldby F, Skipper N, Jones C, Bremner S, Bruce C, Wright J, Lewis M, Newman S, Chevassut T, Hildick-Smith D. Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). Br J Anaesth. 2022;128(5):796–805. https://doi.org/10.1016/j.bja.2022.01.034. This single-center pragmatic randomized trial (INITIATE) by Kong et al. illustrated that preoperative treatment with a single dose of intravenous iron and erythropoiesis-stimulating agents decreased the chance of perioperative blood transfusions in cardiac surgery compared to patients who only received oral iron.CrossRefPubMed

Richards T, Baikady RR, Clevenger B, Butcher A, Abeysiri S, Chau M, Macdougall IC, Murphy G, Swinson R, Collier T, Van Dyck L, Browne J, Bradbury A, Dodd M, Evans R, Brealey D, Anker SD, Klein A. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020;396(10259):1353–61.PubMedPubMedCentralCrossRef

Warner MA, Shore-Lesserson L, Shander A, Patel SY, Perelman SI, Guinn NR. Perioperative anemia: prevention, diagnosis, and management throughout the spectrum of perioperative care. Anesth Analg. 2020;130(5):1364–80.PubMedCrossRef

Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12–23.PubMedCrossRef

Auerbach M, Deloughery T. Single-dose intravenous iron for iron deficiency: a new paradigm. Hematol Am Soc Hematol EducProgram. 2016;2016:57–66.CrossRef

Aapro M, Gascón P, Patel K, et al. Erythropoiesis-stimulating agents in the management of anemia in chronic kidney disease or cancer: a historical perspective. Front Pharmacol. 2018;9:1498.PubMedCrossRef

10.

Palmer SC, Navaneethan SD, Craig JC, et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010;153:23–33.PubMedCrossRef

11.

Tonia T, Mettler A, Robert N, et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev. 2012;12:CD003407.PubMed

12.

So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip- and knee- replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology. 2014;120:839–51.PubMedCrossRef

13.

Weber EW, Slappendel R, Hémon Y, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol. 2005;22:249–57.PubMedCrossRef

14.

Weltert L, Rondinelli B, Bello R, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015;55:1644–54.PubMedCrossRef

15.

Weltert L, D’Alessandro S, Nardella S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg. 2010;139:621–6.PubMedCrossRef

16.

Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929–37.PubMedCrossRef

17.

Whitehead NS, Williams LO, Meleth S, et al. Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review. Crit Care. 2019;23:278.PubMedPubMedCentralCrossRef

18.

Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116(suppl 7A):58S-69S.PubMedCrossRef

19.

Chapin JC, Hajjar KA. fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29:17–24.PubMedCrossRef

20.

Levy JH, Koster A, Quinones QJ, Milling TJ, Key NS. Antifibrinolytic Therapy and Perioperative Considerations. Anesthesiology. 2018;128:657–70.PubMedCrossRef

21.

De Hert S, Gill R, Habre W, Lancé M, Llau J, Meier J, Pouard P, Samama C, Linden J, Linden P, Heyman C. The European society of anaesthesiology task force reports on the place of aprotinin in clinical anaesthesia. Aprotinin: is it time to reconsider?. Eur J Anaesthesiol 2015;32(9):591–5

22.

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S. ATACAS investigators of the ANZCA clinical trials network. Antifibrinolytic therapy tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136–48.PubMedCrossRef

23.

Shi J, Zhou C, Pan W, et al. Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: the OPTIMAL randomized clinical trial. JAMA. 2022;328(4):336–47.PubMedPubMedCentralCrossRef

24.

Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011;93:39–46.PubMedCrossRef

25.

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ. Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. J Knee Surg. 2017;30:460–6.PubMedCrossRef

26.

Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168–86. https://doi.org/10.1097/AOG.0000000000002351

27.

Sentilhes L, Sénat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, Verspyck E, Fuchs F, Azria E, Gallot D, Korb D, Desbrière R, Le Ray C, Chauleur C, de Marcillac F, Perrotin F, Parant O, Salomon LJ, Gauchotte E, Bretelle F, Sananès N, Bohec C, Mottet N, Legendre G, Letouzey V, Haddad B, Vardon D, Madar H, Mattuizzi A, Daniel V, Regueme S, Roussillon C, Benard A, Georget A, Darsonval A, Deneux-Tharaux C, Groupe de Recherche en Obstétrique et Gynécologie. Tranexamic acid for the prevention of blood loss after cesarean delivery. N Engl J Med. 2021;384(17):1623–34.PubMedCrossRef

28.

Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, Longo M, Salazar A, Dalton W, Tita ATN, Gyamfi-Bannerman C, Chauhan SP, Metz TD, Rood K, Rouse DJ, Bailit JL, Grobman WA, Simhan HN, Macones GA, Shriver EK, National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. N Engl J Med. 2023;388(15):1365–75.PubMedPubMedCentralCrossRef

29.

Shakur H, Roberts I, Bautista R, CRASH-2 trial collaborators, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23–32.PubMedCrossRef

30.

CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomized, placebo-controlled trial. Lancet. 2019;394(10210):1713–23. https://doi.org/10.1016/S0140-6736(19)32233-0. Epub 2019 Oct 14. Erratum in: Lancet. 2019 Nov 9;394(10210):1712.CrossRef

31.

World Health Organisation (WHO). Summary of the report of the 18th meeting of the WHO expert committee on the selection and use of essential medicines. Available at: http://www.who.int/selection_medicines/committees/expert/18/en/. Accessed 3 Jun 2023.

32.

Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012;147:113–9.PubMedCrossRef

33.

Gruen RL, Mitra B, Bernard SA, McArthur CJ, Burns B, Gantner DC, Maegele M, Cameron PA, Dicker B, Forbes AB, Hurford S, Martin CA, Mazur SM, Medcalf RL, Murray LJ, Myles PS, Ng SJ, Pitt V, Rashford S, Reade MC, Swain AH, Trapani T, Young PJ. Prehospital tranexamic acid for severe trauma. N Engl J Med. 2023;389(2):127–36.PubMedCrossRef

34.

Thomas W, Samama CM, Greinacher A, Hunt BJ, Subcommittee on Perioperative and Critical Care. The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16:2336–40.PubMedCrossRef

35.

Boer C, Meesters MI, Milojevic M, et al. 2017 EACTS/ EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2018;32:88–120.PubMedCrossRef

36.

Hochleitner G, Sutor K, Levett C, Leyser H, Schlimp CJ, Solomon C. Revisiting Hartert’s 1962 calculation of the physical constants of thrombelastography. Clin Appl Thromb Hemost. 2017;23:201–10.PubMedCrossRef

37.

Deppe AC, Weber C, Zimmermann J, Kuhn EW, Slottosch I, Liakopoulos OJ, et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res. 2016;203:424–33.PubMedCrossRef

38.

Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, et al. Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation. 2016;134:1152–62.PubMedCrossRef

39.

The American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists task force on perioperative blood management. Anesthesiology. 2015;122:241–75.CrossRef

40.

Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34:332–95.PubMedCrossRef

41.

Mamczak CN, Speybroeck J, Stillson JE, Dynako J, Piscoya A, Peck EE, Aboukhaled M, Cancel E, McDonald M, Garcia D, Lovejoy J, Lubin S, Stanton R, Kutcher ME. Viscoelastic hemostatic assays for orthopedic trauma and elective procedures. J Clin Med. 2022;11(14):4029.PubMedPubMedCentralCrossRef

42.

Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, Wohlauer MV, Barnett CC, Bensard DD, Biffl WL, Burlew CC, Johnson JL, Pieracci FM, Jurkovich GJ, Banerjee A, Silliman CC, Sauaia A. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263(6):1051–9.PubMedCrossRef

43.

Amgalan A, Allen T, Othman M, Ahmadzia HK. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women’s SSC of the ISTH. J Thromb Haemost. 2020;18(8):1813–38.PubMedCrossRef

44.

Corey FS, Walker WF. Sonic estimation of elasticity via resonance: a new method of assessing hemostasis. Ann Biomed Eng. 2016;44:1405–24.PubMedCrossRef

45.

Ferrante EA, Blasier KR, Givens TB, Lloyd CA, Fischer TJ, Viola F. A novel device for the evaluation of hemostatic function in critical care settings. Anesth Analg. 2016;123:1372–9.PubMedPubMedCentralCrossRef

46.

Groves DS, Welsby IJ, Naik BI, Tanaka K, Hauck JN, Greenberg CS, Winegar DA, Viola F. Multicenter evaluation of the Quantra QPlus System in adult patients undergoing major surgical procedures. Anesth Analg. 2020;130(4):899–909.PubMedCrossRef

47.

DeAnda A, Levy G, Kinsky M, Sanjoto P, Garcia M, Avandsalehi KR, Diaz G, Yates SG. Comparison of the Quantra QPlus System with thromboelastography in cardiac surgery. J Cardiothorac Vasc Anesth. 2021;35(4):1030–6.PubMedCrossRef

48.

Siegrist KK, Rice MJ. Point-of-care blood testing: the technology behind the numbers. Anesth Analg. 2019;129(1):92–8.PubMedCrossRef

49.

Hirsch FG, Wood LA. The relationship between the erythrocyte concentration and the specific electro conductivity of blood. Bull N Y Acad Med. 1948;24:393.PubMedPubMedCentral

50.

Stewart GN. The relations of the electrolytes to the non-electrolytes in the blood-corpuscles and blood-serum. J Boston Soc Med Sci. 1897;1:18–21.PubMedPubMedCentral

51.

Myers GJ, Browne J. Point of care hematocrit and hemoglobin in cardiac surgery: a review. Perfusion. 2007;22(3):179–83. https://doi.org/10.1177/0267659107080826

52.

Herman J, Park B, Awsare B, et al. Point-of-care versus central testing of hemoglobin during large volume blood transfusion. BMC Anesthesiol. 2019;19:240. https://doi.org/10.1186/s12871-019-0916-2.CrossRefPubMedPubMedCentral

53.

Yang ZW, Yang SH, Chen L, Qu J, Zhu J, Tang Z. Comparison of blood counts in venous, fingertip and arterial blood and their measurement variation. Clin Lab Haematol. 2001;23:155–9.PubMedCrossRef

54.

Kim SH, Lilot M, Murphy LS, et al. Accuracy of continuous noninvasive hemoglobin monitoring: a systematic review and meta-analysis. Anesth Analg. 2014;119:332–46.PubMedCrossRef

55.

Triulzi D, Gottschall J, Murphy E, Wu Y, Ness P, Kor D, Roubinian N, Fleischmann D, Chowdhury D, Brambilla D. NHLBI recipient epidemiology and donor evaluation study-III (REDS-III). A multicenter study of plasma use in the United States. Transfusion. 2015;55(6):1313–9 quiz 1312.PubMedCrossRef

56.

Green L, Roberts N, Cooper J, Agarwal S, Brunskill SJ, Chang I, Gill R, Johnston A, Klein AA, Platton S, Rossi A, Sepehripour A, Stanworth S, Monk V, O’Brien B. Prothrombin complex concentrate vs. fresh frozen plasma in adult patients undergoing heart surgery - a pilot randomised controlled trial (PROPHESY trial). Anaesthesia. 2021;76(7):892–901.PubMedCrossRef

57.

Karkouti K, Bartoszko J, Grewal D, et al. Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. JAMA Netw Open. 2021;4(4):e213936.PubMedPubMedCentralCrossRef

58.

Santana JM, Brovman EY. Prothrombin complex concentrates in cardiac surgery: where are we? Curr Opin Anaesthesiol. 2022;35(1):36–41.PubMedCrossRef

59.

Li JY, Gong J, Zhu F, Moodie J, Newitt A, Uruthiramoorthy L, Cheng D, Martin J. Fibrinogen concentrate in cardiovascular surgery: a meta-analysis of randomized controlled trials. Anesth Analg. 2018;127(3):612–21.PubMedCrossRef

60.

Callum J, Farkouh ME, Scales DC, et al. Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial. JAMA. 2019;322(20):1966–76.PubMedPubMedCentralCrossRef

61.

Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–17.PubMedCrossRef

62.

Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377:2133–44.PubMedCrossRef

63.

Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381–91.PubMedCrossRef

64.

Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Dorée C, Hébert PC. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021;12:CD002042.PubMed

65.

Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, et al. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA. 2021;325(6):552–60 An open-label randomized trial that evaluated a restrictive versus liberal transfusion threshold in patients with acute MI revealed a noninferior rate of MACE at 30 days, but longer term data raised some concerns at the 1-year follow-up.PubMedPubMedCentralCrossRef

66.

Gonzalez-Juanatey JR, Lemesle G, Puymirat E, Ducrocq G, Cachanado M, Arnaiz JA, Martínez-Sellés M, Silvain J, Ariza-Solé A, Ferrari E, Calvo G, Danchin N, Avendano-Solá C, Rousseau A, Vicaut E, Gonzalez-Ferrero T, Steg PG, Simon T, REALITY investigators. One-year major cardiovascular events after restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction and anemia: the REALITY randomized trial. Circulation. 2022;145(6):486–8.PubMedCrossRef

67.

Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC. MINT investigators. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023;257:120–9.PubMedCrossRef

68.

Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus MA, Marroquin OC, Rao SV, Noveck H, Passano E, Hardison RM, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165(6):964-971.e1.PubMedPubMedCentralCrossRef

69.

Spahn DR, Kocian R. Artificial O2 carriers: status in 2005. Curr Pharm Des. 2005;11(31):4099–114.PubMedCrossRef

70.

Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299(19):2304–12.PubMedCrossRef

71.

Weiskopf RB, Beliaev AM, Shander A, Guinn NR, Cap AP, Ness PM, Silverman TA. Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers. Transfusion. 2017;57(1):207–14.PubMedCrossRef

72.

Fontes PA. The evolution of oxygen carrier solutions for machine perfusion. Transplantation. 2017;101(11):2657–8.PubMedCrossRef

73.

Matton APM, Burlage LC, van Rijn R, de Vries Y, Karangwa SA, Nijsten MW, Gouw ASH, Wiersema-Buist J, Adelmeijer J, Westerkamp AC, Lisman T, Porte RJ. Normothermic machine perfusion of donor livers without the need for human blood products. Liver Transpl. 2018;24(4):528–38. https://doi.org/10.1002/lt.25005. Erratum in: Liver Transpl. 2018 Aug;24(8):1151.CrossRefPubMedPubMedCentral

74.

HBO2 Therapeutics. Hemopure, 2022. Retrieved from https://www.hbo2therapeutics.com/our-product. Accessed 2 June 2023.

75.

Mackenzie CF, Dubé GP, Pitman A, Zafirelis M. Users guide to pitfalls and lessons learned about HBOC-201 during clinical trials, expanded access, and clinical use in 1,701 patients. Shock. 2019;52(1S Suppl 1):92–9.PubMedCrossRef

76.

Jahr JS, Guinn NR, Lowery DR, Shore-Lesserson L, Shander A. Blood substitutes and oxygen therapeutics: a review. Anesth Analg. 2021;132(1):119–29.PubMedCrossRef

77.

American Red Cross. Blood donors needed now as omicron intensifies, 2022. Retrieved from https://www.redcross.org/about-us/news-and-events/press-release/2022/blood-donors-needed-now-as-omicron-intensifies.html. Accessed 8 June 2023.

Titel: Perioperative Blood Management Protocols Improve Outcomes: What Does the Future Hold?
verfasst von: Sachin Mehta
Sharon L. McCartney
Nicole R. Guinn
Elliott Bennett-Guerrero
Publikationsdatum: 10.11.2023
Verlag: Springer US
Erschienen in: Current Anesthesiology Reports / Ausgabe 4/2023
Elektronische ISSN: 2167-6275
DOI: https://doi.org/10.1007/s40140-023-00586-w

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Perioperative Blood Management Protocols Improve Outcomes: What Does the Future Hold?